NL-OMON25817招募中不适用
Dexa-Myositis Trial. Treatment of Polymyositis and Dermatomyositis: dexamethason versus prednisone.
未提供0 个研究点目标入组 80 人开始时间: 待定最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 80
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Polymyositis;
- •2. Dermatomyositis;
排除标准
- •1. Myositis in family;
- •2. 3/1000 rimmed vacuoles;
研究者
相似试验
已完成
不适用
Dexa-Myositis Trial: treatment of polymyositis and dermatomyositis - dexamethasone versus prednisoneMyositis, dermatomyositis, polymyositisMusculoskeletal DiseasesMyositisISRCTN48188950Academic Medical Centre (AMC) (Netherlands)80
已完成
3 期
Combined Treatment of Methotrexate + Glucocorticoids Versus Glucocorticoids Alone in Patients With PM and DMPolymyositisDermatomyositisNCT00651040Institute of Rheumatology, Prague31
进行中（未招募）
不适用
A clinical trial to investigate treatment with the drug abatacept in patients with polymyositis and dermatomyositis.Polymyositis and dermatomyositisMedDRA version: 14.1Level: PTClassification code 10036102Term: PolymyositisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersMedDRA version: 14.1Level: PTClassification code 10012503Term: DermatomyositisSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersEUCTR2009-015957-20-GBKarolinska University Hospital20
已完成
不适用
Study of the Prevalence of Polymyositis and Dermatomyositis in NormandyPolymyositisDermatomyositisNCT02880527University Hospital, Rouen187
进行中（未招募）
1 期
Abatacept treatment in polymyositis and dermatomyositis - ARTEMISpolymyositis and dermatomyositisMedDRA version: 12.1Level: LLTClassification code 10036102Term: PolymyositisMedDRA version: 12.1Level: LLTClassification code 10012503Term: DermatomyositisEUCTR2009-015957-20-CZKarolinska University Hospital20